The Canadian Drug Approval Process is misunderstood by many and considered harsh by some. We will explore reasons why the Canadian market should not be overlooked and the benefits of including Canada in strategic drug development initiatives. We will share insights and practical examples that facilitate a positive, proactive and transparent interaction with Health Canada, and provide strategies for avoiding obstacles and managing them efficiently should they occur.
Why Should You Attend:
Learn about common obstacles in the Canadian Drug Development and Approval Process and how to avoid them/overcome them. We will discuss each obstacle in detail and deliver actionable tools to improve your efficiency and increase opportunities for successful market access. You will develop a comprehensive understanding of the Drug Approval Process and in parallel examine major misconceptions and misunderstandings. Our focus will be on key strategic considerations at various stages of the Drug Development Process as well as on demystifying the broader principals of the drug registration approach in Canada.
Areas Covered in the Webinar:
Who Will Benefit:
This webinar is for individuals and companies currently working in a regulatory or business development capacity and considering the demographically desirable Canadian market. Participants will leave with a clear understanding of what the Canadian regulatory landscape is and be able to apply learned principals for avoiding/overcoming the most common obstacles of the Canadian Regulatory environment. Biotech C-suite, decision makers and study sponsors will benefit from participating.
Physical CD-DVD of recorded session will be despatched after 72 hrs on completion of payment
Recorded video session
Founder and President of SPharm, Susanne Picard is a sought-after expert on all aspects of the regulatory landscape. SPharm is a leading regulatory affairs consultancy headquartered in Canada that services clients around the globe. firstname.lastname@example.org.